{"id":"https://openalex.org/W2083274261","doi":"https://doi.org/10.1517/14712598.2.6.607","title":"Current prodrug strategies via membrane transporters/receptors","display_name":"Current prodrug strategies via membrane transporters/receptors","publication_year":2002,"publication_date":"2002-08-01","ids":{"openalex":"https://openalex.org/W2083274261","doi":"https://doi.org/10.1517/14712598.2.6.607","mag":"2083274261","pmid":"https://pubmed.ncbi.nlm.nih.gov/12171505"},"language":"en","primary_location":{"id":"doi:10.1517/14712598.2.6.607","doi":"https://doi.org/10.1517/14712598.2.6.607","is_oa":false,"landing_page_url":"https://doi.org/10.1517/14712598.2.6.607","pdf_url":null,"source":{"id":"https://openalex.org/S57380513","display_name":"Expert Opinion on Biological Therapy","issn_l":"1471-2598","issn":["1471-2598","1744-7682"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Biological Therapy","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014874649","display_name":"Banmeet S. Anand","orcid":"https://orcid.org/0000-0001-6284-3431","observed_orcids":["https://orcid.org/0000-0001-6284-3431"]},"institutions":[{"id":"https://openalex.org/I75421653","display_name":"University of Missouri\u2013Kansas City","ror":"https://ror.org/01w0d5g70","country_code":"US","type":"education","lineage":["https://openalex.org/I75421653"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Banmeet S Anand","raw_affiliation_strings":["Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 5005 Rockhill Road, Kansas City, Missouri 64110-2499, USA","Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 5005 Rockhill Road, Kansas City, Missouri 64110-2499, USA, Tel: +1 816 235 1615","Fax: +1 816 235 5190"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 5005 Rockhill Road, Kansas City, Missouri 64110-2499, USA","institution_ids":["https://openalex.org/I75421653"]},{"raw_affiliation_string":"Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 5005 Rockhill Road, Kansas City, Missouri 64110-2499, USA, Tel: +1 816 235 1615","institution_ids":["https://openalex.org/I75421653"]},{"raw_affiliation_string":"Fax: +1 816 235 5190","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101968754","display_name":"Surajit Dey","orcid":"https://orcid.org/0009-0003-6478-1336","observed_orcids":["https://orcid.org/0009-0003-6478-1336"]},"institutions":[{"id":"https://openalex.org/I75421653","display_name":"University of Missouri\u2013Kansas City","ror":"https://ror.org/01w0d5g70","country_code":"US","type":"education","lineage":["https://openalex.org/I75421653"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Surajit Dey","raw_affiliation_strings":["Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 5005 Rockhill Road, Kansas City, Missouri 64110-2499, USA, Tel: +1 816 235 1615; Fax: +1 816 235 5190;, E-mail: mitraa@umkc.edu","Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 5005 Rockhill Road, Kansas City, Missouri 64110-2499, USA, Tel: +1 816 235 1615","Fax: +1 816 235 5190"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 5005 Rockhill Road, Kansas City, Missouri 64110-2499, USA, Tel: +1 816 235 1615; Fax: +1 816 235 5190;, E-mail: mitraa@umkc.edu","institution_ids":["https://openalex.org/I75421653"]},{"raw_affiliation_string":"Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 5005 Rockhill Road, Kansas City, Missouri 64110-2499, USA, Tel: +1 816 235 1615","institution_ids":["https://openalex.org/I75421653"]},{"raw_affiliation_string":"Fax: +1 816 235 5190","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103328047","display_name":"Ashim K. Mitra","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I75421653","display_name":"University of Missouri\u2013Kansas City","ror":"https://ror.org/01w0d5g70","country_code":"US","type":"education","lineage":["https://openalex.org/I75421653"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ashim K Mitra","raw_affiliation_strings":["Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 5005 Rockhill Road, Kansas City, Missouri 64110-2499, USA, Tel: +1 816 235 1615; Fax: +1 816 235 5190;, E-mail: mitraa@umkc.edu","Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 5005 Rockhill Road, Kansas City, Missouri 64110-2499, USA, Tel: +1 816 235 1615","Fax: +1 816 235 5190"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 5005 Rockhill Road, Kansas City, Missouri 64110-2499, USA, Tel: +1 816 235 1615; Fax: +1 816 235 5190;, E-mail: mitraa@umkc.edu","institution_ids":["https://openalex.org/I75421653"]},{"raw_affiliation_string":"Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 5005 Rockhill Road, Kansas City, Missouri 64110-2499, USA, Tel: +1 816 235 1615","institution_ids":["https://openalex.org/I75421653"]},{"raw_affiliation_string":"Fax: +1 816 235 5190","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I75421653"],"apc_list":null,"apc_paid":null,"fwci":0.4109,"has_fulltext":false,"cited_by_count":65,"citation_normalized_percentile":{"value":0.42019838,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"2","issue":"6","first_page":"607","last_page":"620"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9585000276565552,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9585000276565552,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.031099999323487282,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.00570000009611249,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prodrugs","display_name":"prodrugs","score":0.8650000095367432},{"id":"https://openalex.org/keywords/prodrug-design","display_name":"prodrug design","score":0.8100000023841858},{"id":"https://openalex.org/keywords/membrane-transporters","display_name":"membrane transporters","score":0.9679999947547913},{"id":"https://openalex.org/keywords/receptors","display_name":"receptors","score":0.6320000290870667},{"id":"https://openalex.org/keywords/targeted-drug-delivery","display_name":"targeted drug delivery","score":0.8970000147819519},{"id":"https://openalex.org/keywords/local-drug-delivery","display_name":"local drug delivery","score":0.7860000133514404},{"id":"https://openalex.org/keywords/bioavailability-enhancement","display_name":"bioavailability enhancement","score":0.8270000219345093},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7369999885559082},{"id":"https://openalex.org/keywords/biopharmaceutics","display_name":"biopharmaceutics","score":0.878000020980835}],"concepts":[{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.9678521156311035},{"id":"https://openalex.org/C2910701995","wikidata":"https://www.wikidata.org/wiki/Q679692","display_name":"Biopharmaceutics","level":5,"score":0.7596019506454468},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6377147436141968},{"id":"https://openalex.org/C149011108","wikidata":"https://www.wikidata.org/wiki/Q652985","display_name":"Transporter","level":3,"score":0.6063097715377808},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.5646401047706604},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.502439022064209},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.4411347508430481},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4269981384277344},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4180881977081299},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4152190685272217},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.31742337346076965},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.208012193441391},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.11981326341629028},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.11068576574325562},{"id":"https://openalex.org/C160492267","wikidata":"https://www.wikidata.org/wiki/Q319616","display_name":"Pharmacognosy","level":4,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000212","descriptor_name":"Acyclovir","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D000596","descriptor_name":"Amino Acids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001205","descriptor_name":"Ascorbic Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D001692","descriptor_name":"Biological Transport","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002462","descriptor_name":"Cell Membrane","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008956","descriptor_name":"Models, Chemical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011355","descriptor_name":"Prodrugs","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1517/14712598.2.6.607","doi":"https://doi.org/10.1517/14712598.2.6.607","is_oa":false,"landing_page_url":"https://doi.org/10.1517/14712598.2.6.607","pdf_url":null,"source":{"id":"https://openalex.org/S57380513","display_name":"Expert Opinion on Biological Therapy","issn_l":"1471-2598","issn":["1471-2598","1744-7682"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Biological Therapy","raw_type":"journal-article"},{"id":"pmid:12171505","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12171505","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on biological therapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8048999905586243,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1374044781","display_name":"Ocular Disposition of Antimicrobial Agents","funder_award_id":"R01EY009171","funder_id":"https://openalex.org/F4320337350","funder_display_name":"National Eye Institute"},{"id":"https://openalex.org/G1452432274","display_name":"SYNTHESIS OF NEW ANTIHIV AGENTS RELATED TO COSALANE","funder_award_id":"R01AI036624","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G5789911894","display_name":"Cellular Efflux and Metabolism of Protease Inhibitors","funder_award_id":"R01GM064320","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"},{"id":"https://openalex.org/G6597212008","display_name":"Transscleral Transport & Polymeric Delivery of Antibody & Steroids for Macular Ed","funder_award_id":"R01EY010659","funder_id":"https://openalex.org/F4320337350","funder_display_name":"National Eye Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337350","display_name":"National Eye Institute","ror":"https://ror.org/03wkg3b53"},{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":120,"referenced_works":["https://openalex.org/W25509686","https://openalex.org/W64426755","https://openalex.org/W164276519","https://openalex.org/W170938872","https://openalex.org/W199840660","https://openalex.org/W221716308","https://openalex.org/W335068570","https://openalex.org/W335092241","https://openalex.org/W345827556","https://openalex.org/W1132977027","https://openalex.org/W1486882165","https://openalex.org/W1489650506","https://openalex.org/W1498354276","https://openalex.org/W1504507024","https://openalex.org/W1517698775","https://openalex.org/W1538099673","https://openalex.org/W1559370499","https://openalex.org/W1563807700","https://openalex.org/W1571579514","https://openalex.org/W1573615374","https://openalex.org/W1602491094","https://openalex.org/W1751983523","https://openalex.org/W1809078632","https://openalex.org/W1896305083","https://openalex.org/W1914743657","https://openalex.org/W1919810009","https://openalex.org/W1920541914","https://openalex.org/W1956844386","https://openalex.org/W1969923083","https://openalex.org/W1974899753","https://openalex.org/W1980530258","https://openalex.org/W1981793850","https://openalex.org/W1983197885","https://openalex.org/W1983430641","https://openalex.org/W1985420286","https://openalex.org/W1985524812","https://openalex.org/W1986731020","https://openalex.org/W1991701465","https://openalex.org/W1992229605","https://openalex.org/W1995825628","https://openalex.org/W1995921345","https://openalex.org/W1996943508","https://openalex.org/W2008166341","https://openalex.org/W2011194792","https://openalex.org/W2013187640","https://openalex.org/W2016573829","https://openalex.org/W2017469703","https://openalex.org/W2022686948","https://openalex.org/W2022980838","https://openalex.org/W2027760441","https://openalex.org/W2041140779","https://openalex.org/W2041609743","https://openalex.org/W2046924313","https://openalex.org/W2047687145","https://openalex.org/W2049202898","https://openalex.org/W2049222379","https://openalex.org/W2049453920","https://openalex.org/W2053179898","https://openalex.org/W2054542253","https://openalex.org/W2057354396","https://openalex.org/W2061553666","https://openalex.org/W2063722936","https://openalex.org/W2064963948","https://openalex.org/W2065754451","https://openalex.org/W2067410858","https://openalex.org/W2067650742","https://openalex.org/W2068178457","https://openalex.org/W2069603879","https://openalex.org/W2071277783","https://openalex.org/W2074670161","https://openalex.org/W2075280347","https://openalex.org/W2079405203","https://openalex.org/W2082979575","https://openalex.org/W2083504073","https://openalex.org/W2085076392","https://openalex.org/W2085901675","https://openalex.org/W2086058048","https://openalex.org/W2086644935","https://openalex.org/W2088158673","https://openalex.org/W2088228850","https://openalex.org/W2088579951","https://openalex.org/W2088627708","https://openalex.org/W2092682849","https://openalex.org/W2097542876","https://openalex.org/W2099023080","https://openalex.org/W2100025400","https://openalex.org/W2101017561","https://openalex.org/W2102584369","https://openalex.org/W2103777616","https://openalex.org/W2105830875","https://openalex.org/W2114847750","https://openalex.org/W2123340537","https://openalex.org/W2128890618","https://openalex.org/W2129571862","https://openalex.org/W2131436933","https://openalex.org/W2136237275","https://openalex.org/W2140330186","https://openalex.org/W2140626944","https://openalex.org/W2141028699","https://openalex.org/W2141161750","https://openalex.org/W2149407579","https://openalex.org/W2151164311","https://openalex.org/W2151391614","https://openalex.org/W2152567653","https://openalex.org/W2157857106","https://openalex.org/W2160446964","https://openalex.org/W2162817417","https://openalex.org/W2164752182","https://openalex.org/W2164841350","https://openalex.org/W2168811983","https://openalex.org/W2175811212","https://openalex.org/W2180387024","https://openalex.org/W2182830530","https://openalex.org/W2255539187","https://openalex.org/W2273806688","https://openalex.org/W2327640792","https://openalex.org/W2338026443","https://openalex.org/W2343100729","https://openalex.org/W4232270366","https://openalex.org/W4406056595"],"related_works":["https://openalex.org/W2006670903","https://openalex.org/W2027549805","https://openalex.org/W2088158673","https://openalex.org/W2115062514","https://openalex.org/W1971877476","https://openalex.org/W2026126810","https://openalex.org/W7161604918","https://openalex.org/W2172224337","https://openalex.org/W1998593954","https://openalex.org/W4413462091"],"abstract_inverted_index":{"Prodrug":[0],"design":[1,26,89],"strategies":[2],"have":[3,61],"been":[4,62],"employed":[5],"to":[6,40,44,75],"improve":[7],"the":[8,66,85,95],"delivery":[9],"of":[10,22,38,68],"drugs":[11,39],"with":[12],"undesirable":[13],"pharmacokinetic":[14],"properties":[15],"such":[16],"as":[17,52],"chemical":[18],"stability":[19],"and":[20,33,42,55,71],"lack":[21],"specificity.":[23],"Targeted":[24],"prodrug":[25,88],"represents":[27],"a":[28,53],"new":[29],"strategy":[30],"for":[31],"site-directed":[32],"efficient":[34],"drug":[35],"delivery.":[36],"Targeting":[37],"transporters":[41],"receptors":[43],"aid":[45],"in":[46,64,80,87,94],"site-specific":[47],"carrier-mediated":[48],"absorption":[49],"is":[50],"emerging":[51],"novel":[54],"clinically":[56],"significant":[57],"approach.":[58],"Various":[59],"prodrugs":[60],"successful":[63],"achieving":[65],"goals":[67],"enhanced":[69],"bioavailability":[70],"are,":[72],"therefore,":[73],"considered":[74],"be":[76],"an":[77],"important":[78],"tool":[79],"biopharmaceutics.":[81],"This":[82],"review":[83],"highlights":[84],"advances":[86],"targeted":[90],"towards":[91],"membrane":[92],"transporters/receptors":[93],"past":[96],"few":[97],"years.":[98]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}